Ablative Radiation Therapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma

被引：0
|
作者：
Tao, R. [1 ]
Krishnan, S. [1 ]
Bhosale, P. [1 ]
Javle, M. [1 ]
Shroff, R. [1 ]
Kaseb, A. [1 ]
Jensen, G. [1 ]
Bishop, A. J. [1 ]
Swanick, C. W. [1 ]
Koay, E. J. [1 ]
Thames, H. D. [1 ]
Hong, T. S. [2 ]
Das, P. [1 ]
Crane, C. H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
256
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [21] Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma
    Huertas, Andres
    Baumann, Anne-Sophie
    Saunier-Kubs, Fleur
    Salleron, Julia
    Oldrini, Guillaume
    Croise-Laurent, Valerie
    Barraud, Helene
    Ayav, Ahmed
    Bronowicki, Jean-Pierre
    Peiffert, Didier
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 (02) : 211 - 216
  • [22] Prognostic Value of Morphofunctional Imaging Methods In Post-Therapy Inoperable Intrahepatic Cholangiocarcinoma
    Dragonetti, V.
    Fraccascia, N.
    Mosconi, C.
    Barakat, M.
    Palloni, A.
    Paccapelo, A.
    Golfieri, R.
    Brandi, G.
    Fanti, S.
    Nanni, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S471 - S472
  • [23] Osteopenia Is Associated with Shorter Survival in Patients with Intrahepatic Cholangiocarcinoma
    Miki, Atsushi
    Sakuma, Yasunaru
    Watanabe, Jun
    Endo, Kazuhiro
    Sasanuma, Hideki
    Teratani, Takumi
    Lefor, Alan Kawarai
    Kitayama, Joji
    Sata, Naohiro
    CURRENT ONCOLOGY, 2023, 30 (02) : 1860 - 1868
  • [24] Predictive factors for survival time of inoperable hilar cholangiocarcinoma patients
    Srikhajonjit, Supatra
    Mairiang, Pisaln
    Mairiang, Eimorn
    Sangchan, Apichat
    Sawadpanitch, Kookwan
    Thavornpitak, Yupa
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 426 - 426
  • [25] Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma
    Chinchilla-Lopez, Pauline
    Aguilar-Olivos, Nancy E.
    Garcia-Gomez, Jaime
    Hernandez-Alejandro, Karen K.
    Chable-Montero, Fredy
    Motola-Kuba, Daniel
    Patel, Tushar
    Mendez-Sanchez, Nahum
    ANNALS OF HEPATOLOGY, 2017, 16 (04) : 565 - 568
  • [26] Role of Definitive Radiation Therapy of Intrahepatic Cholangiocarcinoma As Primary Treatment for Patients at High Risk
    Cho, Y.
    Seong, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E146 - E146
  • [27] Clinical factors associated with the survival of patients with intrahepatic cholangiocarcinoma
    Ting, Chun-Fu
    Huang, Wen-Hsin
    Feng, Chun-Lung
    Yu, Cheng-Ju
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Lai, Hsueh-Chou
    Cheng, Ken-Sheng
    Chuang, Po-Heng
    Kao, Jung-Ta
    ADVANCES IN DIGESTIVE MEDICINE, 2016, 3 (01) : 11 - 17
  • [28] Predictors of Survival in Intrahepatic Cholangiocarcinoma Treated With Stereotactic Body Radiation Therapy: A National Cancer Database Study
    Straza, Michael W.
    Gamblin, Thomas C.
    Robbins, Jared R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E21 - E22
  • [29] Stereotactic Body Radiation Therapy for Unresectable Intrahepatic and Hilar Cholangiocarcinoma
    Mahadevan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S12 - S12
  • [30] Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma
    Alicia C. Smart
    Lipika Goyal
    Nora Horick
    Natasa Petkovska
    Andrew X. Zhu
    Cristina R. Ferrone
    Kenneth K. Tanabe
    Jill N. Allen
    Lorraine C. Drapek
    Motaz Qadan
    Janet E. Murphy
    Christine E. Eyler
    David P. Ryan
    Theodore S. Hong
    Jennifer Y. Wo
    Annals of Surgical Oncology, 2020, 27 : 1122 - 1129
12345